QualityStocks.net News – BSD Medical Corp. (BSDM) to Distribute Cancer Fighting Hyperthermia System in Italy and Europe

At www.QualityStocks.Net you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and Micro-Cap online Investment Newsletters are interested in, plus hear about the latest news from our clients as well as other publicly traded companies.

We would like to highlight BSD Medical Corp. (NASDAQ: BSDM). The company is a leading developer of systems used to provide cancer therapies requiring precision-focused heat through RF/microwave technologies. For further information, visit BSD Medical's website at www.BSDMedical.com.

In the company’s news yesterday,

BSD Medical Corp. announced its European distributor was awarded a contract from Azienda Ospedaliera Institui Ospitalieri Di Verona (the Institute) to replace its existing hyperthermia system with BSD’s BSD-2000/3D system. The BSD-2000/3D deep regional hyperthermia system is scheduled for delivery in August 2008, and will replace the Institute’s current system, which has been used since 1996. The BSD-2000/3D will be the first of its kind in Italy, and the 15th utilized in Europe.

“We are pleased to further expand our activities in the field of clinical hyperthermia, the single most potent radiation sensitizer available. We are looking forward to close working relationships with all of the ESHO [European Society for Hyperthermic Oncology] member institutes in advancing hyperthermia cancer treatment,” Dr. Sergio Maluta, head of the Radiation Oncology Department at the Institute stated in the press release.

The hyperthermia system uses 3-D steering to allow for a precisely focused energy to be administered into cancerous tumors, raising the tumor’s temperature to levels required for hyperthermia therapy to destroy the cancer cells with heat. The technology even allows for the treatment of tumors located deep in the body, increasing the effectiveness of radiation therapy.

The technology is integral to the Institute, which conducts more than 40,000 radiation treatments each year. As a member of ESHO, the Institute partakes in numerous major European clinical hyperthermia trials to treat several cancers, including advanced prostate cancer, as well as rectal, cervical, bladder, breast, head and neck cancer.

About QualityStocks

QualityStocks.net, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks.net is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

Please see disclaimer on QualityStocks.net website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.